Hastalar, kendi karaciğerlerini "kendileri yetiştirecek": Biyoteknoloji şirketi LyGenesis Salı günü yaptığı açıklamada, bir kişinin lenf düğümleri içinde minyatür karaciğerler yetiştirmek üzere tasarlanan tedavisinin faz II denemesine başlandığını duyurdu. https://t.co/6tFMVdxeym

I'd like to think that I've gained many things from knowing @MichaelHufford of @HRTherapeutics @ @LyGenesis_Inc. But this gif stands tall.

Congrats to @LyGenesis_Inc @MichaelHufford on the latest financing! Can't wait to read about more progress with your groundbreaking therapies.

Associate Director of Liver Transplantation Dr. Constance Mobley discusses the @LyGenesis_Inc LYG-LIV-02-001 Phase 2a clinical trial evaluating the potential of allogeneic hepatocyte transplantation for organ regeneration in patients living with ESLD. ▶️: https://t.co/6D50MvODP4

Another early-stage biotech deal in Pittsburgh - Imagine Pharma raises over $32 million to further novel medical product development on the heals of rounds by @abridgehq & @LyGenesis_Inc https://t.co/NIMtA9ROMS via @PittsburghInno

LyGenesis bags $19m to complete key clinical trial and advance cell therapy pipeline https://t.co/6koHjb8n22

Just to make the point that if you ever convince yourself that all you do is win, consider that @MichaelHufford runs @LyGenesis_Inc AND @HRTherapeutics and still has time to be a cool AF cat.

For the first time, a human has received an experimental therapy that turns lymph nodes into mini livers. "[It] is something very extraordinary, to an extent a little bit science fiction," says Eric Lagasse at @LyGenesis_Inc Read more: https://t.co/tCOp9hsMLs

LyGenesis and Imagine Pharma to jointly develop cell therapies for Patients with Type 1 diabetes https://t.co/iECjzuArdM #LyGenesis #Dr.MichaelHufford #NgocThai #ImaginePharma @indpharmapost

Listen to @LyGenesis_Inc CEO @MichaelHufford and Prime Movers Lab Partner @gavinmathis on the latest episode of the Prime Movers podcast to discuss the future of liver transplants and regenerative medicine. Lygenesis has found a way to turn lymph nodes into bioreactors to grow

Biotech startup LyGenesis raises $19 million to complete ongoing clinical trial of regenerative cell therapy https://t.co/MfOhmcEXDD via @Pittsburgh Inno

LyGenesis bags $19m to complete key clinical trial and advance cell therapy pipeline @PrimeMoversLab and @juvlabs back @LyGenesis_Inc through its Phase 2a liver disease trial. #longevity #investment #liver https://t.co/qxEoq6UqZs

เริ่ม Phase 2a ทดสอบการสร้างตับเทียม (ectopic liver) โดยใช้เซลล์ตับจากผู้บริจาคปลูกถ่ายในต่อมน้ำเหลืองของผู้ป่วยที่เป็นโรคตับระยะสุดท้าย (end-stage liver disease, ESLD) แล้ว โดยหวังว่าต่อมน้ำเหลืองจะทำหน้าที่แทนตับอย่างน้อยชั่วคราวก่อนผ่าตัดเปลี่ยนตับ

Terapia que transforma gânglios linfáticos em fígados passa pelo primeiro ensaio clínico em humanos https://t.co/bfRMysUesf @LyGenesis_Inc #Linfonodo #Fígado #InsuficiênciaHepática #GângliosLinfáticos

🗞️ The biotechnology firm LyGenesis has injected donor cells into a person with liver failure for the first time. If successful, the treatment will lead them to grow an additional "mini liver". https://t.co/V9ky6A8dLA

A major accomplishment worthy of vast recognition and praise. Congrats to the entire team @LyGenesis_Inc on this major milestone!

‘Mini liver’ will grow in person’s own lymph node in bold new trial... Biotechnology firm LyGenesis https://t.co/uHNIVlGDvt

.@PrimeMoversLab & @JuvLabs back cell therapy company, @LyGenesis with $19Mil Series A-2 through Phase 2a clinical trial, centered on the development of ectopic livers for individuals afflicted with end-stage liver disease https://t.co/4i2XCQR4oz via @LongevityTech

#UnitedStates startup LyGenesis Raises $19M Series A Round